USD
+$0.00
(+0.00%
)At Close (As of Oct 24, 2025)
$5.16M
Market Cap
0.0226
P/E Ratio
90.8
EPS
$22.95
52 Week High
$1.10
52 Week Low
HEALTHCARE
Sector
| Field | Value (USD) |
|---|---|
| Gross Profit | $11M |
| Total Revenue | $23M |
| Cost Of Revenue | $12M |
| Costof Goods And Services Sold | $12M |
| Operating Income | -$8.2M |
| Selling General And Administrative | $4.5M |
| Research And Development | $3.8M |
| Operating Expenses | $8.2M |
| Investment Income Net | - |
| Net Interest Income | $25K |
| Interest Income | $25K |
| Interest Expense | -$6K |
| Non Interest Income | - |
| Other Non Operating Income | - |
| Depreciation | - |
| Depreciation And Amortization | $4K |
| Income Before Tax | -$8.2M |
| Income Tax Expense | - |
| Interest And Debt Expense | - |
| Net Income From Continuing Operations | -$8.2M |
| Comprehensive Income Net Of Tax | - |
| Ebit | -$8.2M |
| Ebitda | -$8.2M |
| Net Income | -$8.2M |
| Field | Value (USD) |
|---|---|
| Total Assets | $5.7M |
| Total Current Assets | $5.6M |
| Cash And Cash Equivalents At Carrying Value | $5M |
| Cash And Short Term Investments | $5M |
| Inventory | - |
| Current Net Receivables | - |
| Total Non Current Assets | $124K |
| Property Plant Equipment | - |
| Accumulated Depreciation Amortization Ppe | - |
| Intangible Assets | - |
| Intangible Assets Excluding Goodwill | - |
| Goodwill | - |
| Investments | - |
| Long Term Investments | - |
| Short Term Investments | - |
| Other Current Assets | $587K |
| Other Non Current Assets | - |
| Total Liabilities | $1.7M |
| Total Current Liabilities | $1.6M |
| Current Accounts Payable | $897K |
| Deferred Revenue | - |
| Current Debt | - |
| Short Term Debt | $96K |
| Total Non Current Liabilities | $71K |
| Capital Lease Obligations | $119K |
| Long Term Debt | - |
| Current Long Term Debt | - |
| Long Term Debt Noncurrent | - |
| Short Long Term Debt Total | $119K |
| Other Current Liabilities | $643K |
| Other Non Current Liabilities | - |
| Total Shareholder Equity | $4M |
| Treasury Stock | - |
| Retained Earnings | -$40M |
| Common Stock | - |
| Common Stock Shares Outstanding | $183K |
| Field | Value (USD) |
|---|---|
| Operating Cashflow | -$8.6M |
| Payments For Operating Activities | - |
| Proceeds From Operating Activities | - |
| Change In Operating Liabilities | - |
| Change In Operating Assets | - |
| Depreciation Depletion And Amortization | $4K |
| Capital Expenditures | $0 |
| Change In Receivables | - |
| Change In Inventory | - |
| Profit Loss | - |
| Cashflow From Investment | - |
| Cashflow From Financing | $12M |
| Proceeds From Repayments Of Short Term Debt | - |
| Payments For Repurchase Of Common Stock | - |
| Payments For Repurchase Of Equity | - |
| Payments For Repurchase Of Preferred Stock | - |
| Dividend Payout | - |
| Dividend Payout Common Stock | - |
| Dividend Payout Preferred Stock | - |
| Proceeds From Issuance Of Common Stock | - |
| Proceeds From Issuance Of Long Term Debt And Capital Securities Net | - |
| Proceeds From Issuance Of Preferred Stock | - |
| Proceeds From Repurchase Of Equity | -$1K |
| Proceeds From Sale Of Treasury Stock | - |
| Change In Cash And Cash Equivalents | - |
| Change In Exchange Rate | - |
| Net Income | -$8.2M |
| Field | Value (USD) |
|---|---|
| Gross Profit | $11M |
| Total Revenue | $23M |
| Cost Of Revenue | $12M |
| Costof Goods And Services Sold | $12M |
| Operating Income | -$8.2M |
| Selling General And Administrative | $4.5M |
| Research And Development | $3.8M |
| Operating Expenses | $8.2M |
| Investment Income Net | - |
| Net Interest Income | $25K |
| Interest Income | $25K |
| Interest Expense | -$6K |
| Non Interest Income | - |
| Other Non Operating Income | - |
| Depreciation | - |
| Depreciation And Amortization | $4K |
| Income Before Tax | -$8.2M |
| Income Tax Expense | - |
| Interest And Debt Expense | - |
| Net Income From Continuing Operations | -$8.2M |
| Comprehensive Income Net Of Tax | - |
| Ebit | -$8.2M |
| Ebitda | -$8.2M |
| Net Income | -$8.2M |
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
None